Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

House Bill

H.R. 4392

119th Congress

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

In Committee

Introduced:Jul 15, 2025

Primary Sponsor

Mariannette Miller-Meeks

Representative

Republican

IA-1

Cosponsors

87

Quick Stats

Policy Area

Health

Summary

This bill would require private and public health insurance plans to cover HIV prevention drugs without any cost-sharing or preauthorization requirements for patients. It would also prohibit insurance companies from denying or limiting certain other insurance policies based on someone taking HIV prevention medication. Additionally, the bill would provide grants to help uninsured and underinsured individuals access HIV prevention treatments.

Latest Action

Referred to the Subcommittee on Health.

SponsorMariannette Miller-Meeks (R-IA)

Introduced7/15/2025

StatusReferred to the House Committee on Energy and Commerce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

This bill would require private and public health insurance plans to cover HIV prevention drugs without any cost-sharing or preauthorization requirements for patients. It would also prohibit insurance companies from denying or limiting certain other insurance

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require private and public health insurance plans to cover HIV prevention drugs without any cost-sharing or preauthorization requirements for patients. It would also prohibit insurance companies from denying or limiting certain other insurance policies based on someone taking HIV prevention medication. Additionally, the bill would provide grants to help uninsured and underinsured individuals access HIV prevention treatments.

Bill Number: 4392
Sponsor: Mariannette Miller-Meeks (R-IA)
Introduced: 7/15/2025
Status: Referred to the House Committee on Energy and Commerce.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Bill Number: 4392
Sponsor: Mariannette Miller-Meeks (R-IA)
Status: Referred to the House Committee on Energy and Commerce.
Introduced: 7/15/2025
Summary: This bill would require private and public health insurance plans to cover HIV prevention drugs without any cost-sharing or preauthorization requirements for patients. It would also prohibit insurance companies from denying or limiting certain other insurance policies based on someone taking HIV pre

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require private and public health insurance plans to cover HIV prevention drugs without any cost-sharing or preauthorization requirements for patients. It would also prohibit insurance companies from denying or limiting certain other insurance policies based on someone taking HIV prevention medication. Additionally, the bill would provide grants to help uninsured and underinsured individuals access HIV prevention treatments.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

PrEP Access and Coverage Act of 2023 This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services (HHS) to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment. HHS, the Department of Labor, and the Department of Treasury must enforce and report on private insurers' compliance with the bill's requirements.

Key Points

Main provisions of the bill

Requires private and public health insurance to cover HIV prevention drugs without any cost-sharing or preauthorization requirements for patients
Prohibits insurance companies from denying or limiting certain other insurance policies based on someone taking HIV prevention medication
Provides grants to help uninsured and underinsured individuals access HIV prevention treatments

How This Impacts Americans

Potential effects on citizens and communities

If this bill becomes law, it would make it easier and more affordable for people to access HIV prevention drugs, which could lead to a decrease in new HIV infections. This would particularly benefit uninsured and underinsured individuals who may have previously struggled to afford or access these important preventative treatments.

Policy Areas

Primary Policy Area

Health

Related Subjects

Child health

Civil actions and liability

Congressional oversight

Disability and health-based discrimination

Government employee pay, benefits, personnel management

HIV/AIDS

Health care costs and insurance

Health care coverage and access

Health programs administration and funding

Health promotion and preventive care

+9 more

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4392, 119th Congress (2025). "Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4392